Literature DB >> 17071562

Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen.

Sergio M Borgia1, Jeffrey D Fuller, Alicia Sarabia, Philippe El-Helou.   

Abstract

Cerebral blastomycosis is a rarely reported disease. We report three cases of cerebral blastomycosis previously treated with standard antifungal therapy, which were subsequently successfully treated with voriconazole. The first is a 29-year-old man who initially presented with concomitant cutaneous and osseous blastomycosis; the second is a 50-year-old man who initially presented with prostatic, pulmonary and cutaneous lesions. The third patient was a 63-year-old man who presented with hemiplegia and multiple intra-cerebral blastomycomas. This report represents the first two documented relapses, in Canada, of CNS blastomycosis following treatment with itraconazole and, to our knowledge, among the first three worldwide human cases of cerebral blastomycosis treated successfully with voriconazole.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071562     DOI: 10.1080/13693780600803870

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  10 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

2.  Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) in fulminant blastomycosis in Germany.

Authors:  Markus Resch; Katrin Kurz; Wulf Schneider-Brachert; Kathrin Tintelnot; Christoph Birner; Thomas Schichtl; Matthias Lubnow; Christina Hart; Clemens Jilek; Simone Bertz; Michael Hilker; Günter A J Riegger; Andreas Luchner; Thomas Müller
Journal:  BMJ Case Rep       Date:  2009-06-28

Review 3.  Clinical and laboratory update on blastomycosis.

Authors:  Michael Saccente; Gail L Woods
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

4.  The role of second-generation antifungal triazoles for treatment of the endemic mycoses.

Authors:  Alison G Freifeld; J Ryan Bariola; David Andes
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

5.  Voriconazole use for endemic fungal infections.

Authors:  Alison Freifeld; Laurie Proia; David Andes; Larry M Baddour; Janis Blair; Brad Spellberg; Sandra Arnold; Arnold Lentnek; L Joseph Wheat
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

Review 6.  Successful treatment of osseous blastomycosis without pulmonary or disseminated disease and review of the literature.

Authors:  Shandra R Day; David B Weiss; Kevin C Hazen; Christopher C Moore
Journal:  Diagn Microbiol Infect Dis       Date:  2014-03-07       Impact factor: 2.803

Review 7.  Central Nervous System Infection with Other Endemic Mycoses: Rare Manifestation of Blastomycosis, Paracoccidioidomycosis, Talaromycosis, and Sporotrichosis.

Authors:  Carol A Kauffman
Journal:  J Fungi (Basel)       Date:  2019-07-18

8.  Infections of the nervous system.

Authors:  Vevek Parikh; Veronica Tucci; Sagar Galwankar
Journal:  Int J Crit Illn Inj Sci       Date:  2012-05

9.  Intracranial blastomycotic abscess mimicking malignant brain neoplasm: Successful treatment with voriconazole and surgery.

Authors:  Kanika Arora; Ross L Dawkins; David F Bauer; Cheryl A Palmer; James R Hackney; James M Markert
Journal:  Surg Neurol Int       Date:  2015-11-20

Review 10.  Histoplasmosis and Blastomycosis in Solid Organ Transplant Recipients.

Authors:  Carol A Kauffman; Marisa H Miceli
Journal:  J Fungi (Basel)       Date:  2015-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.